Danny Luan
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Ultrasound in Clinical Applications
Papers in
- Oncology 7
- CAR-T cell therapy research 7
-
- Lymphoma Diagnosis and Treatment 3
- Co-authors
- Gabriel Martinez-Santibañez (2 shared papers)Taleen A. Mergian (2 shared papers)Lynn M. Geletka (2 shared papers)Carey Nien-Kai Lumeng (2 shared papers)Kae Won Cho (2 shared papers)Brian F. Zamarron (2 shared papers)Lindsey A. Muir (2 shared papers)Kanakadurga Singer (2 shared papers)
- Journals
- Blood (2 papers)Transplantation and Cellular Therapy (2 papers)Diabetes (2 papers)Blood Cancer Journal (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesIsraelSouth Korea
In The Last Decade
Danny Luan
26 papers receiving 472 citations
Danny Luan's Hit Papers
Peers
Comparison fields: 5 of 52
- Hematology 61
- Critical Care and Intensive Care Medicine 13
- Epidemiology 89
- Transplantation 8
- Oncology 32
Countries citing papers authored by Danny Luan
This map shows the geographic impact of Danny Luan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Luan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Luan more than expected).
Fields of papers citing papers by Danny Luan
This network shows the impact of papers produced by Danny Luan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Luan. The network helps show where Danny Luan may publish in the future.
Co-authors
The 25 scholars most cited alongside Danny Luan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 131 | |
| 2 | Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study Hit paper breakdown → | 2024 | 74 |
| 3 | 2016 | 43 | |
| 4 | Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype. | 1995 | 27 |
| 5 | 2022 | 27 | |
| 6 | 2015 | 26 | |
| 7 | 2019 | 26 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 15 | |
| 10 | 2024 | 14 | |
| 11 | 2024 | 11 | |
| 12 | 2018 | 9 | |
| 13 | 2025 | 9 | |
| 14 | 2025 | 9 | |
| 15 | 2018 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2021 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2026 | 4 |
About Danny Luan
Danny Luan is a scholar working on Oncology, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine, Hematology and Public Health, Environmental and Occupational Health, having authored 29 papers that have together received 483 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Lymphoma Diagnosis and Treatment (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), Multiple Myeloma Research and Treatments (2 papers), Ultrasound in Clinical Applications (1 paper), Atrial Fibrillation Management and Outcomes (1 paper), Genomics and Chromatin Dynamics (1 paper) and Cardiovascular Disease and Adiposity (1 paper). The work is most often cited by research in Hematology (61 citations), Critical Care and Intensive Care Medicine (13 citations), Epidemiology (89 citations), Transplantation (8 citations) and Oncology (32 citations). Danny Luan has collaborated with scholars based in United States, Israel and South Korea. Frequent co-authors include Gabriel Martinez-Santibañez, Taleen A. Mergian, Lynn M. Geletka, Carey Nien-Kai Lumeng, Kae Won Cho, Brian F. Zamarron, Lindsey A. Muir, Kanakadurga Singer, Jennifer L. DelProposto and Dongqing Wang. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Diabetes, Blood Cancer Journal and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.